Senators Demand Turkey Extradite Hamas Terrorists
Democrats Set the Standard for 'Unqualified'
We Might Have a Problem With Trump's Labor Secretary Nominee
Trump Makes His Pick for Treasury Secretary
Trump Clinches Another Win in Hush Money Case. How Some Libs Reacted.
The Proverbial Sacrificial Lamb
One of Trump’s Biggest Allies Says He’s Never Getting Into Politics Again
America's National Debt Just Hit a New Record
The View Forced to Read Three Legal Notes Within Minutes of One Another...
Watch This ABC Reporter Goes on Massive Tangent Blaming Trump for Laken Riley's...
Guess Who Joe Biden Just Awarded the Highest Civilian Honor To
Are Teens Leaning More Conservative or Liberal? Here’s What a New Poll Is...
Here's What the DOJ Is Demanding of Google
Georgia Conducted a Hand Count Audit of Its Election Results. Guess What it...
Top Pollster Calls on Joe Biden to Resign
Tipsheet

Johnson & Johnson Vaccine Gets Thumbs Up from FDA Staff

AP Photo/Mel Evans

Staff for the U.S. Food and Drug Administration found that the Johnson & Johnson coronavirus vaccine is safe and effective, meaning it may soon be the third vaccine to get the agency's approval. What makes this news stand out is that unlike the vaccines from Pfizer-BioNTech and Moderna, the Johnson & Johnson vaccine requires only a single dose.

Advertisement

While the Johnson & Johnson jab showed 66% effectiveness overall as opposed to the other vaccines, which have efficacy rates in the 90s, the company notes that their vaccine was shown to prevent 100% of hospitalizations after performing a clinical study of around 44,000 patients in the U.S., South Africa and other countries.

J&J submitted its Covid vaccine data to the FDA on Feb. 4. The vaccine’s level of protection varied by region, J&J said, with the shot demonstrating 66% effectiveness overall, 72% in the United States, 66% in Latin America and 57% in South Africa, where the B.1.351 variant is rapidly spreading. However, the FDA staff documents show the vaccine was 64% effective in South Africa after about a month. The company said the vaccine prevented 100% of hospitalizations and deaths. (CNBC)

Advertisement

The FDA’s Vaccines and Related Biological Products Advisory Committee will meet on Friday to discuss Johnson & Johnson's emergency authorization request, meaning we could get word of an approval as early as this weekend.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement